CCR9 and infection: Although we do not have evidence to prove these hypotheses, given that CD4+CCR9+α4β7+ serve as viral targets [32], our results may point to ongoing infection and damage at mucosal sites even in the course of effective treatment, thus highlighting the role of this population in the pathogenesis of HIV disease within the gastrointestinal tract.